Financhill
Sell
50

STRO Quote, Financials, Valuation and Earnings

Last price:
$12.65
Seasonality move :
-14.43%
Day range:
$11.14 - $11.99
52-week range:
$5.23 - $21.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.01x
P/B ratio:
1.64x
Volume:
156K
Avg. volume:
115.2K
1-year change:
-39.74%
Market cap:
$100.1M
Revenue:
$62M
EPS (TTM):
-$17.75

Earnings Data

Next earnings date for STRO
--
Most recent earnings per share
-$6.70
Missed by $3.15
(Sep 30/2025)
Consensus Estimate
-$3.55
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $7.6M -- -- -- --
12/31/2025 Q4 $8.3M -- -- -$4.43 --
09/30/2025 Q3 $9.1M $9.7M -$6.70 -$3.55 -$3.15
08/11/2025 Q2 $14.3M $63.7M -$1.36 -$5.30 $3.94
05/12/2025 Q1 $11.6M $17.4M -$0.91 -- --
03/13/2025 Q4 $12.2M $14.8M -$8.78 -$9.55 $0.77
11/13/2024 Q3 $15.3M $8.5M -$0.59 -$7.35 $6.76
08/13/2024 Q2 $21M $25.7M -$0.59 -$9.00 $8.41
05/13/2024 Q1 $12.1M $13M -$0.95 -$9.95 $9.00
03/25/2024 Q4 $13.2M $113.7M $0.51 -$8.41 $8.92
11/13/2023 Q3 -- $16.9M -$0.81 -- --
08/10/2023 Q2 -- $10.4M -$0.64 -- --
05/15/2023 Q1 -- $12.7M -$0.85 -- --
03/30/2023 Q4 -- $8.6M -$0.61 -- --
11/08/2022 Q3 -- $25.1M -$0.37 -- --
08/08/2022 Q2 -- $28.1M -$0.55 -- --
05/09/2022 Q1 -- $5.9M -$0.84 -- --
02/28/2022 Q4 -- $10.7M -$0.82 -- --
11/10/2021 Q3 -- $8.5M -$0.67 -- --
08/09/2021 Q2 -- $28M -$0.13 -- --
05/07/2021 Q1 -- $14.7M -$0.66 -- --
03/18/2021 Q4 -- $8.3M -$1.48 -- --
11/05/2020 Q3 -- $17.8M $0.45 -- --
08/06/2020 Q2 -- $9.5M $0.94 -- --
05/11/2020 Q1 -- $7.2M -$0.84 -- --
03/16/2020 Q4 -- $11.3M -$0.64 -- --
11/08/2019 Q3 -- $12.3M -$0.56 -- --
08/14/2019 Q2 -- $10.5M -$0.60 -- --
04/01/2019 Q1 -- $8.6M -$0.62 -- --
12/31/2018 Q4 -- $19.1M -$0.07 -- --
11/14/2018 Q3 -- $7.8M -$0.45 -- --
12/31/2017 Q4 -- $4M -$6.72 -- --
09/30/2017 Q3 -- $17.5M -$0.06 -- --

Sutro Biopharma, Inc. Earnings Questions

  • How Much did Sutro Biopharma, Inc. Generate in Revenue Last Quarter?

    Sutro Biopharma, Inc. reported $9.7M worth of top line sales in its most recent quarter.

  • Did Sutro Biopharma, Inc. Beat Earnings Last Quarter?

    Sutro Biopharma, Inc. announced earnings per share of -$6.70 which represents a miss of analyst forecast a -$3.55 per share.

  • Is Sutro Biopharma, Inc. Profitable?

    Sutro Biopharma, Inc. reported $7.8M that represents $0.92 per share over the last quarter.

  • What is the Analyst Consensus for Sutro Biopharma, Inc. EPS Next Year?

    Sutro Biopharma, Inc.'s earnings are forecast to decrease from -$29.61 per share to -$19.40 per share next year representing a decrease of -34.47%.

  • When is Sutro Biopharma, Inc.'s Earnings Date?

    Currently, Sutro Biopharma, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
65
RGC alert for Jan 9

Regencell Bioscience Holdings Ltd. [RGC] is up 8.33% over the past day.

Buy
58
KRUS alert for Jan 9

Kura Sushi USA, Inc. [KRUS] is up 2.57% over the past day.

Buy
53
PBF alert for Jan 9

PBF Energy, Inc. [PBF] is up 0.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock